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Executive Summary 
 
 
The AutoSyringe is an automatic device that allows patients with limited dexterity to 
administer medication to themselves as painlessly as possible.  The device allows patients 
to inject themselves subcutaneously, where the needle goes into the fat layer between the 
outer skin and the muscle.  In this study, given a constant pressure applied at the plunger, 
the flow of medication through the barrel and needle of a syringe was modeled in terms 
of velocity and pressure.  Furthermore, through this model it was found that the flow rate 
at the tip of the needle decreases with increased viscosity of the medication.  It was also 
determined that the flow rate increases with increased applied pressure at the plunger.  
These analyses were performed using the software package FIDAP, PreSTO, with 
imported geometry from GAMBIT. 
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Introduction and Design Objectives 
 
 
AutoSyringe is an automatic needle/injection device used to treat patients who suffer 
from diseases that require chronic injection therapy, such as multiple sclerosis.  The 
syringe is designed to deliver the medication to the patient at a steady rate allowing for a 
quick, painless injection.  The injections are often subcutaneous (Figure 1) where the 
needle goes into the fat layer between the outer skin and the muscle to deliver a certain 
amount of medication.  These injections are administered on a part of the body that 
contains enough of fat layer to easily deliver the medicine into the correct area, such as 
the outer surface of the upper arm, top of the thighs, and the buttocks. 
 
 
Figure 1. Various types of needle injection 
 
 
Design Objectives 
 
The goal of this study is to model the flow of medication through the barrel and needle 
(Figure 2) of a syringe.  In order to accurately model this we will be specifically 
interested in how this fluid behaves during injection into a porous tissue.  This interaction 
between fluid and tissue will allow for us to set appropriate boundary conditions at the 
ejection tip of the needle.  After preliminary research we have found scientific support for 
treating tissue as a porous media. 
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“As is well known, biological systems are comprised of porous capillary 
beds and cells that are heterogeneous, multi-phasic, and surface-
dominated.  Therefore, treating the tissues as a porous media, which 
consists of solid particles and water is reasonable (Gui, 74).” 
 
The software will be able to model the tissue as porous media.  Further investigation into 
the abilities of the software and the nature of tissue/fluid interaction will allow for an 
accurate model to be depicted. 
 
 
Figure 2. Basic structure and parts of a syringe 
 
 
Objective Outline: 
1. Model diffusivity of medication though a 27 gauge needle. 
2. Determine pressures necessary to drive medication based on various tissue 
conditions, assuming tissue as a porous media. 
3. Use axis symmetry to model the barrel and needle 
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 4
 
G (0.0202,0.01,0) N (0.03638,0.01,0) H (0.0505,0.01,0)  
 
B (0,0.004318,0) C (0.02,0.004318,0) 
D (0.0205,0.00021,0) E (0.03638,0.00021,0) 
J (0,0.00021,0) L (0.0505,0.00021,0) 
 
 A (0,0,0) K (0.0205,0,0) F (0.03638,0,0) I (0.0505,0,0) 
 
 Needle = 27 gauge (0.42mm diameter) and 5/8” long (1.59cm) 
 Barrel diameter = 0.340” (0.86cm) 
 
Table 1: List of Edges of within our model and their boundary type 
 Names Boundary Type 
A→F SyringeAxis Plot 
E→F NeedleTip Plot 
D→E NeedleSide Plot 
A→B SyringeTop Plot 
B→C SyringeSide Plot 
C→D SyringeCone Plot 
D→G SkinSurface Plot 
G→H SkinSide Plot 
H→I SkinDeep Plot 
F→I SkinAxis Plot 
 
Note:  The boundary type ‘Wall’ is specific for a fluid continuum where a no-slip 
condition is desired, that is the velocity of the fluid is 0 at the wall of the barrel. 
 
We must separate our problem into two regions.  The first part deals with fluid flow 
through the syringe as a result of the movement of the plunger down the barrel.  The 
second part of our problem describes the movement of the drug once it enters the tissue. 
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Results and Discussion 
 
 
Overall, we were able to effectively model the injection of drug through a 1 ml syringe 
into the tissue.  The following velocity vector plot (Figure 3) shows the fluid entering the 
needle. As it entered the needle, the velocity increased dramatically, while in the syringe 
the velocity of the fluid was minimal. In addition, as the fluid approached the axis of 
symmetry of the needle, the velocity of the fluid was the greatest, while the fluid velocity 
approached zero at the wall of the needle due to the no slip condition that was set as one 
of our boundary conditions on the needle wall.  The no slip condition was illustrated 
more dramatically in Figure 4 of the velocity contour plot as the shaded blue area.  
 
 
Figure 3: Velocity Vector Plot of fluid entering the needle from the syringe 
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Figure 4: Velocity Contour Plot of fluid entering the tissue from the needle 
 
The following velocity vector plot (Figure 5) showed the fluid exiting the needle and 
entering the tissue. Again, the largest velocity occurred at the axis of symmetry.  
However, once it entered the tissue, the velocity slowed down as shown in the plot. 
Eventually, the velocity of the fluid slowed down dramatically as it diffused further away 
from the end of the needle. Once the velocity due to pressure from the needle slowed in 
the tissue, diffusion and blood flow (not accounted for in our model) would carry the 
drug (in this case water) away from the needle tip.   
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Figure 5: Velocity Vector Plot of fluid entering the tissue from the needle 
 
The contour plot (Figure 6) shown below depicts the pressures throughout the entire 
model.  The greatest pressure occurred in the syringe, which was most likely due to the 
constant pressure that was applied to the barrel of the syringe within our boundary 
conditions.  Within the needle, the pressure gradually decreased to equilibrate with that of 
the low pressure found within the tissue.  This makes sense because we set the pressure 
equal to zero (gauge pressure) far away from the injection site in the surrounding tissue.  
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Figure 6: Pressure Contour Plot of the syringe, needle, and tissue 
 
 
Sensitivity Analysis 
 
Our sensitivity analysis involved the changing of certain variables important to our model.  
The variables tested included constant pressure at the top of the barrel, viscosity of the 
drug, permeability, porosity, and density.  The variable chosen to reflect changes in our 
model due to variation in parameters was the average flow rate through the end on the 
needle tip.  All parameters were tested, however three of our 5 parameters did not affect 
the flow rate through the needle; these will be explained later.   
 
The first major parameter tested was that of the pressure applied to the plunger.  This 
parameter was determined and set by the company as one of the specifications to be met 
by the auto syringe design.  It was determined the plunger would have a constant force of 
10 pounds applied to the plunger to force a drug out of the syringe.  The pressure was 
determined by using the cross sectional area and the specified force.  We then varied this 
parameter by 10% in each direction to see its affect on flow rate out of the needle.  As 
expected and seen in Figure 7, an increase in pressure (i.e. force) would increase the flow 
rate in the needle.   
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Figure 7:  The flow rate of the fluid at the tip of the needle with ±10% variation of the applied pressure of 
10 pounds of force at the plunger. 
 
Our second major variable analyzed was the used of different drug viscosity; assuming 
use of different drugs in the auto syringe in the market place.  The range of viscosities 
tested was extremely large due an inability to find viscosity values of drugs found in 
today’s market.  The viscosity was varied 20% and 50% in each direction to account for 
the unknown actual values (Figure 8).  Intuitively, increasing the viscosity of the drug 
decreased the flow rate through the needle tip; this is seen in Figure 8 below.  This made 
sense as a thicker fluid is more difficult to pass through a tube or flow.  As a note, FIDAP 
asked the user to provide a viscosity not only for the drug but for the entity of the tissue.  
This tissue viscosity was assumed to be the viscosity of the drug flowing through its 
pores; making it necessary to change both the viscosity of the entity drug and the entity 
tissue by the same percentage for the sensitivity analysis.   
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Figure 8:  The effect on the flow rate of the fluid at the tip of the needle with ± 20% and ± 50% variation 
from the viscosity of water for the drug viscosity. 
 
The other three variables tested, drug density, tissue permeability, and porosity, all 
showed no affect on the flow rate through the needle.  No affect due to drug density is 
easy to explain, as in the flow rate equation there is no term to take density into account.  
Any change made to the density would therefore have no affect on flow rate through the 
needle tip.  The permeability and porosity both had no affect on the flow rate through the 
needle tip.  This will be explained below.   
 
For the most part, our results were expected.  The affect of changing pressure at the 
plunger and viscosity of the drug were very intuitive for anticipating a change in flow 
rate.  However, the change in permeability and porosity were not expected.  Originally, 
the team thought that an increase in permeability or porosity would increase the flow rate 
out of the needle as less resistance was encountered at the needle tip.  In contrast, a 
decrease in permeability or porosity would create a backpressure that would in essence 
slow down the flow rate through the needle tip.  However, neither of these situations was 
the case.  When varying the permeability and porosity, no change was elicited in the flow 
rate of our fluid.  After analyzing all possible graphs, an important clue was found in the 
pressure contour graph (Figure 6).  The pressure drop from the constant set at the barrel 
to the gauge pressure in the skin is observed completely in the needle.  This would 
suggest that all resistance to the fluid is encountered in the needle and makes this portion 
of the model a limiting factor.  Since we are limited by the needle, any changes made in 
the permeability or porosity of the tissue had no affect on the flow rate.  One possible 
way to examine this sensitivity would be to change the size of the needle to make the 
tissue the limiting factor.   
 
 11
Conclusions and Design Recommendations 
 
 
Our design objective was to model the flow of medication through the barrel and needle 
of a syringe.  It is clear through our results that we were successful in this objective.  We 
also set out to determine the effect of several variables on this flow model.  Our results 
show that at lower viscosities with constant applied pressure, the velocity increases.  We 
also see that a result of higher pressure results in a similar increase in velocity.  Therefore, 
we can conclude that drugs with lower viscosity would require less applied pressure on 
the plunger.  Drug viscosity, therefore, is a very important factor to consider when 
determining the necessary pressure application.  It is important to consider this 
conclusion in terms of design requirements.  The team should research the different drugs 
for which this device could be used for (i.e. medications for MS, Diabetes, Rheumatoid 
Arthritis, etc).  The medication with the high drug viscosity should then be used to set the 
threshold of pressure necessary.  However, if there is a wide range of viscosities it is 
important to make sure that the threshold set would still represent a safe pressure for use 
with lower end viscosities.  
 
The results also show that porosity and permeability of the tissue had no observable 
effect on the flow model.  The model only accounted for flow within the needle, however, 
and did not consider flow into the tissue as the readings were taken as an average at the 
tip.  Therefore, since porosity and permeability are not in the momentum equation, these 
variables would not be factors in the results.  One way to resolve the issue of the effect of 
permeability and porosity would be to examine flow rate values just within the tissue.  A 
difficulty with this solution could be that when the fluid leaves the needle tip it spreads 
out in all directions.  Therefore, the multiple pathways that the fluid could take might 
limit the effect of these variables on fluid flow in the tissue.  The needle proved to be a 
limiting factor rather than the fluid build-up in the tissue because the small diameter of 
the needle is what slows down fluid flow, not resistance due to back pressure from the 
tissue.    More assumptions were made in modeling the tissue than were made in 
modeling the needle.  In addition, the properties of the tissue will vary from patient to 
patient whereas the properties of the needle will remain constant. Therefore, it is 
advantageous for us to have the limiting factor be in the needle.   
 
The conclusions above are essential to continuing this project to its completion and 
creating a physical auto-injection device.  However, there are still several realistic 
constraints which we must face.  This model relies on a constant pressure applied to the 
top of the plunger.  In order to apply this pressure the team must develop a feasible power 
source which can provide the necessary force output.  Our ultimate objective is to design 
a power source that can drive the fluid flow needed to deliver medication to a patient.  In 
this project we were required to use a 27 gauge needle.  Since we’ve determined that 
needle gauge and length are the limiting factors in fluid flow, we should further analyze 
different needle sizes to develop an overall picture of the required pressures.  Further, the 
power source must be economically feasible.  If the device is to be disposable then there 
can’t be an additional cost greater than 3 to 5 cents.  However if the device is reusable the 
cost can vary depending on many injections it will last for.  Additionally, a high upfront 
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cost may prove to be a barrier to market uptake.  The power source must also fall well 
within all health and safety requirements.  There must be adequate control over the 
source as well as significant testing to prove it’s efficacy of delivery.    
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Appendix A 
 
 
Governing Equations: The Syringe 
 
Since we are engaged in a problem that deals with mass transfer, we are interested in the 
Conservation of Momentum that occurs in the syringe.  For this we use the 2-D Navier-
Stokes equation. 
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Our problem assumes that there is no heating or cooling of the drug while traveling 
through the syringe.  As a result, we are not interested in the Energy Conservation 
Equation.  The velocity along the glass boundary will also be zero according to laws of 
fluid flow. 
 
We also must consider the continuity equation of the fluid. 
 
∂vx
∂x +
∂vy
∂y = 0 
 
 
Boundary Conditions: The Syringe 
 
• Left side (the plunger) has constant pressure; P = P0 
• The side of the barrel will have a no slip condition where v = 0 [m/s] 
• The syringe is completely insulated (no heat loss) 
 
 
Governing Equation: The Tissue 
 
In this portion, we are concerned with how the drug will disperse and diffuse into the 
tissue from the penetration site.  For this, we will have to evaluate the velocity of the drug 
in this region, and the following equation: 
 
( ) ( ) '''''' 22
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1 uuu
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c
k
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Boundary Conditions: The Tissue 
 
• Far away from the injection site, the pressure is equal to the atmosphere 
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• Drug velocity is 0 far away from the injection site 
• We specify for initial solution, the initial velocity profile for the fluid in the 
syringe as a parabolic velocity profile with the equation  v = 4.76x10-4(1 –
( r2/(.021)2)) 
• There is no drug initially in the tissue 
 
 
Constant Parameters 
• Drug viscosity = 0.00089 kg/(m*s) 
• Tissue drug density= 1.05 X 103 kg/m3 
• Tissue Porosity = 0.3 
• Skin permeability = 5.61 *10-9 h*m2/g 
• Effective viscosity = viscosity/2 
 
 
Note: We assumed the drug has the same properties of water for the preliminary solution. 
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Appendix B 
 
 
Problem Statement 
 
The search to discover the next “big drug” is never ending.  While much work has been 
done to develop these life altering medicines, we rarely consider the methods by which 
we deliver these drugs.  As a result, more recent research is being conducted to develop 
novel drug delivery systems, such as implantables and transdermal patches.  However, 
the problem remains that we rely on syringes, or more specifically needles, to deliver 
much of our medicine.  Perhaps the reason is we have come to expect manually operated 
syringes as the industry standard for drug delivery.  Perhaps something better has yet to 
come along. 
 
On the other hand, we must understand that not all patients are able to inject themselves 
with the current syringe technology.  Most likely the lack of dexterity required to operate 
the syringe is the problem.  Whether they suffer from diseases like Multiple Sclerosis or 
Parkinson’s, which directly affect the control of body movements, or the patient is 
limited by the effects of aging, ultimately self injection is just not possible.   
 
Whatever the case, an opportunity has developed to help these disabled people and 
individuals requiring self-injections.   Transitioning the traditional syringe from manual 
operation to automatic has distinct advantages to those self-injecting individuals.  Besides 
ease of use, an automatic syringe requires less energy from the user, while still 
administering the correct dosage.  As stated previously, automatic syringe technology 
already exists.  However, none can incorporate traditional glass or plastic syringes used 
today.  These technologies require a completely new device to achieve automatic delivery. 
 
The problem, in concept, is basic.  We must transform a conventional syringe into an 
automatic device, while preserving the standardized design.  In essence, we want to keep 
the barrel and needle, but replace the plunger with a controllable power device that can be 
operated simply and safely by the user.  In doing so, we would like to develop a computer 
model that will allow us to analyze the variables intrinsic to the syringe and skin tissue 
that can affect the required pressure necessary for a complete injection.  These variables 
include drug density, drug viscosity, skin density, skin permeability, and skin porosity.  
Upon completion of the model, we will have a complete understanding of the injection 
process and can base power designs off of our conclusions. 
 
 
Solution statement 
 
Our solution integrates a multitude of biological and physical variables that can affect the 
operation of an automatic syringe.  With the use of GAMBIT, PreSTO, and FIDAP 
software, we were able to develop models to analyze pressure and fluid velocities in the 
syringe and tissue surrounding the injection site.  We found that the majority of the 
pressure loss was in the needle, which would correspond with the high fluid velocities we 
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encountered in the region.  In addition, our solution indicated that the effect of skin 
parameters, such as porosity and permeability, did not contribute any additional 
resistance to the fluid flow.  As a result of our model, we have determined that altering 
needle gauge and length will be the largest factor in determining the pressure required for 
a complete injection.  Further research, both computational and experimental, should be 
conducted to confirm our findings.  
 
 
Time Integration Statement 
 
Company requirements for the time allotted for an injection is three seconds.  However, 
our computer model required us to incorporate two regions, one of fluid, and the other of 
a porous media.  Due to the difficult nature of the problem, we elected to run a steady 
state time integration instead of a transient model.  As a result, we do not see the fluid 
flow develop in the syringe, only the steady state result.  Nevertheless, we would expect a 
similar solution to the steady state when three seconds into the transient model.  
Therefore, we still find our steady state model to be an accurate representation of the 
injection process. 
 
 
Mesh Convergence 
 
Figure 9:  Increasing mesh densities used to evaluate solution convergence.  The top left is the least dense, 
while the bottom right was most dense and used as the geometry for analysis. 
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Figure 9 above depicts the various densities of mesh we used in arriving at a final 
geometry suitable for further analysis.  We approached nearly 40,000 total nodes before 
reaching mesh convergence (Figure 10).  Fine mesh was most critical in the needle 
portion of the syringe and at the needle tip as the fluid was ejected.  Initially, we did not 
concentrate as much on the tip of the needle.  However, we noticed that our solution was 
not generating the fluid velocity in the tissue close to the needle tip as expected.  As we 
refined the mesh, we discovered that fluid flow was occurring, but the mesh was not fine 
enough to show an accurate picture.  Therefore, we used the bottom right picture of the 
mesh (Figure 9) because it offered the best depiction of the fluid flow out of the syringe. 
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Figure 10:  The flow rate at the tip of the needle as a function of the amount of total nodes in the geometry. 
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Appendix C 
 
 
Drug Flow Rate at the Tip of the Needle
with Varying Permeability of the Skin
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Figure 11:  The effect on the flow rate of the fluid at the tip of the needle with ± 50% variation in 
permeability value.  No change in the flow rate was elicited. 
 
 
Drug Flow Rate at the Tip of the Needle
with Varying Tissue Porosity
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Figure 12:  The effect on the flow rate of the fluid at the tip of the needle with ± 10% variation in porosity.  
No change in the flow rate was elicited. 
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